WE ARE DIGID, THE HEALTH-TECH COMPANY FOR DIGITAL DIAGNOSTICS.
We make personal health measurable and enable consumers to take clear decisions immediately.
Illustrative prototype– Copyright: Digital Diagnostics AG
digid was founded in Mainz in 2019. Based on more than ten years of university research, we are developing a digital diagnostics system that enables real-time diagnostics, nearly everywhere. AI-supported, it processes results directly to secure databases and mobile devices such as personal mobile phones or tablet computers. Always with the goal in mind to turn measurement values into valuable knowledge that is safely available – anywhere, anytime, and easy to understand.
THE FUTURE OF PERSONAL DIAGNOSTICS FITS IN EVERY POCKET.
Why detour via a laboratory when you can take it directly with you? Our rapid Covid-19 antigen test is based on digid’s proprietary Cantisense™ – biosensor technology. It is the heart of our measurement system. Given the size of a grain of rice, it enables diagnostics directly at the point of care. In real time, an accurate picture of your personal fitness status and performance can be created, such enabling clear decisions, immediately.
Our measurement principle is based on a highly sensitive micro-electro-mechanical system (MEMS). Micro-cantilevers (bending bars) coated with antibodies can bind viruses and bacteria according to the lock-and-key principle. When a binding event occurs, the cantilevers begin to bend. This micromechanical motion is detected electronically. The inherent digital signal is then displayed to the user on the tablet computer.
Copyright: Digital Diagnostics AG
Digital Diagnostics AG (digid), founded 2019 in Mainz, Germany
Based on +10 years of interdisciplinary university research
Novel, highly sensitive MEMS technology
Development of biosensors for reliable measurements
ONE TEA TAKES
ENOUGH TIME FOR A CORONA TEST.
COVID-19 has become a daily stress factor. The uncertainty about a possible infection is ubiquitous. There’s a constant struggle how the risks can be reduced with heightened safety and hygiene measures. What the options are to return to a normal life. Therefore it is ever more important to find fast security with targeted testing, to be able to follow and break the lines of infection.
SPEED MEETS ACCURACY: THE CANTISENSE™ CORONA ANTIGEN TEST.
digid has developed one of the first digital SARS CoV-2 antigen rapid tests worldwide. The Cantisense™ SARS-CoV-2 Test is created as a pocket-sized lab and can be used anywhere on site by general practitioners, paramedics and nursing staff without any specific training procedures. Digital results immediately available to other connected systems and enabling AI-solutions.
Principle of the direct SARS-CoV-2 virus antigen test:
The binding of the SARS-CoV-2 virus on the antibody layer causes the cantilever to bent, which can be measured by the digid technology.
DIGID CANTISENSE™ TEST SYSTEM
ON THE SPOT ANALYSIS WITHOUT SAMPLE PREPARATION
TESTING WHERE IT IS MOST IMPORTANT.
We offer fast and reliable testing options for critical or public infrastructure. Possible applications include access control at airports and railway stations, hospitals, especially protected environments, such as retirement and nursing homes, as well as for companies who want to ensure that their production runs smoothly and safely. We enable testing patients and medical staff quickly and easily on site, without the time- and cost consuming detour via a laboratory – in order to identify infections within minutes.
A SINGLE TECHNOLOGY.
A THOUSAND POSSIBILITIES.
With our innovative approach, we not only want to make an important contribution to faster containment of the corona virus. In addition we also have the ability to react quickly to other diseases and offer real-time diagnostics – from influenza to diabetes and cancer. A multi-marker platform for multiple possibilities. In a manner of speaking, a multi-marker platform for multiple possibilities.
WHY WE GIVE OUR BEST
IF YOU WANT TO CHANGE THE WORLD, YOU NEED STRONG PARTNERS.
Digital Diagnostics AG is a fast-growing Health-Tech Company. We welcome everyone who wants to improve people’s lives with digital diagnostics and is and is willing to break new ground with us. If you have any questions regarding investments and strategic partnerships, please feel free to contact us.
WITH OUR DEVELOPMENT.
Know more about our current developments, as well as topics and trends in the digital diagnostic. Nehmen Sie Kontakt zu uns auf.
At the Helmholtz Centre for Infection Research (HZI), scientists have succeeded for the first time in detecting SARS-CoV-2 viruses using the revolutionary Cantisense™ technology from Digital Diagnostics AG. Application for approval of the Digid Cantisense™ SARS-CoV-2...
A consortium of scientists and companies is developing a new 5 minute test for the SARS corona virus. In comparison to currently available rapid tests, the SARS-CoV-2 MEMS 5 Minute Test™ directly detects the virus over the entire course of the infection and can be...
SOURCE: ECDC | EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL
OUR TEAM IS LOOKING FOR
When we speak about us, we’re not just talking about a health tech company. We talk about a big exciting adventure that only just began. And we know that we can only succeed as a team.
We’re always looking for curious heads who want to join us.
Get in touch at firstname.lastname@example.org